key: cord-0036114-4lmsl1qv
authors: Tachibana, Hiroshi; Takekoshi, Masataka
title: Production of Antibody Fab Fragments in Escherichia coli
date: 2011-05-06
journal: Antibody Expression and Production
DOI: 10.1007/978-94-007-1257-7_8
sha: dfb929fa1767a69f21b29554d11ce74ddc61db88
doc_id: 36114
cord_uid: 4lmsl1qv

A phage-display library is the most broadly used platform for preparation of recombinant human monoclonal antibody Fab fragments. Panning is effective for the selection of immunoglobulin genes from naïve and immune libraries. However, it is possible to bypass the phage display system if human peripheral lymphocytes are obtained from seropositive patients with infectious diseases as a source of immunoglobulin genes. Direct screening of bacterial colonies producing Fab fragments by colony blotting using filter membranes is practical for the isolation of human Fab fragments to major antigens of pathogens. An oligoclonal culture can also be used, and is a partial application of Epstein-Barr virus transformation of peripheral lymphocytes. Using these procedures, neutralizing antibody Fab fragments to various antigens can be obtained with a sufficient level of cloning efficacy. Chain shuffling and site-directed mutagenesis are also useful ways to improve the quality of the cloned antibody Fab fragments.

The immunoglobulin molecule is a complex structure of four polypeptide chains organized as a homodimer of a heterodimer comprising heavy and light chains. The proteolytic enzyme papain cleaves the molecules into two identical Fab (fragment, antigen binding) fragments and one Fc (fragment, crystallization) fragment, since the enzyme cuts above hinge disulfide bond(s) in the heavy chains. Thus, the Fab fragment is composed of a light chain consisting of a variable region (VL) and a constant region (CL) and the Fd region of the heavy chain containing a variable region (VH) and a constant region (CH1). The domains formed by the two variable regions bind the epitope as a specific antigen.

Several methods for preparation of human monoclonal and polyclonal antibodies have been developed through advances in molecular biology, with the goal of therapeutic use of antibodies (Hoet et al., 2005; Kuroiwa et al., 2002; Mendez et al., 1997; Tomizuka et al., 1997) . Application of a phage display system (Smith, 1985) is an effective method for expression of a huge repertoire of immunoglobulin genes Thie et al., 2008) . Using this system, valuable Fab fragments can be selected from the gene library Burton et al., 1991) . The methods and protocols for phage display have been described in detail in reviews and books (Barbas et al., 2001 ). An antibody Fv fragment composed of only the variable regions (VH-VL), and especially a single chain Fv (scFv), can also be prepared using phage display technology (Bird et al., 1988) and is frequently used because of its better tolerance and expression in bacteria in comparison with a Fab fragment (Mondon et al., 2008) . However, Fab fragments are more stable than scFv due to the association between the CH1 and CL regions.

In this chapter, we describe the production of recombinant human Fab fragments in Escherichia coli. In addition to phage display followed by screening using panning, a method that allows bypassing of the panning process is introduced.

Phagemid-based systems are most commonly used among a variety of phage display systems. Phagemids contain origins for replication of E. coli and filamentous phage (M13, fl or fd), a group of viruses that infect E. coli (Mead and Kemper, 1988) . A phage particle consists of a single-stranded DNA (ssDNA) genome. The phage surface has 3-5 copies of phage coat protein-3 (pIII), which is involved in host cell recognition and infection. The major coat protein is phage coat protein-8 (pVIII), which covers the length of the particle with approximately 2,700 copies that contribute to the structural stability of the phage particle (Russel, 1991) . Thus, phagemid combines the characteristics of a plasmid (antibiotic resistance and facilitation of replication of double-stranded DNA (dsDNA)) with those of a phage (production and packaging of ssDNA into a phage particle). Light chain and Fd region genes are cloned into appropriate sites. Secretion signal sequences (e.g. pelB, ompA or PhoA) are coupled to both genes, which allow secretion of Fd and light chain fragments into the periplasm fraction of E. coli. The Fab fragment is fused to pIII or its C-terminal domain to allow display on the phage surface.

Recombinant phagemids are introduced into competent E. coli by electroporation ( Fig. 8.1 ). Transformation efficiency is critical because it has a direct influence on library size; therefore, electrocompetent cells are better than normal competent cells. After transformation, E. coli is superinfected with helper phage (e.g. VCS M13) to give a whole phage particle. Helper phages have a slightly defective origin of replication and phagemid DNA is dominantly packaged into the phage particle. Synthesized Fd and light chain fragments are transported to the periplasm and a 8, pIII is transferred to the periplasm. 9, Phagemid is packaged in a virion. 10, Phagemid moves out of cells with Fab and normal pIII S-S bond forms between the fragments in the reducing environment. Fab fragments with fused pIII are displayed on the phage surface concomitant with wild-type pIII provided by helper phages. As a result, recombinant phage can infect E. coli. Some phagemids utilize pVIII as a Fab fusion protein. However, high valency display libraries generally lead to low affinity Fab fragments due to avidity effects.

Fab-pIII fusion proteins may be toxic to cells, resulting in gene deletion and plasmid instability. Stringent control of fusion protein expression during the propagation steps is critical. In general, lac promoter is used to drive gene expression in phagemid vectors; thus, accommodation of leaky expression is needed. Then glucose is added, or lac repressor is overexpressed to elevate metabolic activatorregulated repression. A robust terminator upstream of the lac promoter also reduces the background expression (Krebber et al., 1996) . The tet promoter (tetracycline inducible promoter) can be used as an alternative approach (Zahn et al., 1999) . With this promoter, gene expression is tightly repressed in the absence of an inducer such as doxycycline or tetracycline. A phage display system connects the genotype (antibody genes packaged in phage particles) and phenotype (Fab on the surface of phage particles). Affinity selection or biopanning is then needed to isolate Fab fragments against a range of antigens.

Immunoglobulin genes encoding Fab fragments can be isolated from immunized (immune library) or nonimmunized (naïve library) donors. An immune library is suitable for generation of Fab fragments for targeting with high affinity and specificity. The sources of immunoglobulin genes may be bone marrow, spleen, tonsils or peripheral blood lymphocytes (PBLs). Bone marrow is the ideal source, but is difficult to obtain. PBLs are most commonly used and one-step RT-PCR enables construction of libraries with sufficient amounts of heavy (γ and μ) and light-chain (κ and λ) genes using pairs of Fab specific primers. A naïve library is constructed from IgM mRNA of B cells taken from a nonimmunized donor. Antibodies from naïve libraries generally show weaker affinity, but the library size is larger and the chance of obtaining specific antibodies with affinity against the target is increased (de Haard et al., 1999) . A large library is constructed through combination of heavy and light chain genes cloned individually in each library.

Semi-synthetic libraries have been used to merge natural and synthetic diversity. For example, the VH region of the library has been created from semi-synthetic complementarity determining regions (CDRs) 1 and 2 with natural CDR3 from 35 donors with autoimmune diseases and 10 normal donors (Hoet et al., 2005) . Synthetic libraries composed of 6 oligonucleotide-derived CDRs for heavy and light chains have diversity that is almost the same as that obtained naturally (Rothe et al., 2008; Shi et al., 2010) . Affinities of up to 100 pM have been shown for Fab fragments from these libraries, and semi-synthetic and synthetic libraries are commercially available.

Selection of phages with Fab fragments reactive to antigen is performed by panning ( Fig. 8 .2). Phage particles presenting Fab fragments are incubated over an immobilized antigen of choice in ELISA plates or immunotubes Marks et al., 1991) . Non-binding phage are removed by washing. Phages that bind to the antigen are eluted by changing the binding conditions (e.g. pH change or competitive elution) and amplified by re-infection of E. coli cells. The amplified phages are then subjected to further rounds of panning with gradual increases in the frequency and intensity of the washing conditions. The panning process has a combination of positive selection (affinity and specificity) and negative selection (toxicity to bacterial cells and a tendency to delete unnecessary DNA), and 2-3 selection rounds may be preferable. To recover Fabs that are tightly bind to antigen, proteolytic enzyme digestion is used to cut a protease site between the Fab and pIII (Ward et al., 1996) .

Some membrane proteins are difficult to produce in soluble form, and protein folding is critical to obtain the epitope conformation. In cells displaying antigen, protein is produced in mammalian cells and displayed on the cell surface. In some cases, antigen-negative cells are used as absorber cells to bind Fab fragments: the absorber cells work to remove sticky clones (de Kruif et al., 1995) . Cell sorting (Siegel et al., 1997) . Yeast Saccharomyses cerevisiae is also used as a cell display platform (van den Beucken et al., 2003) , but the transformation efficiency is not as high and the Fab library size is limited. Ribosome display has been developed to expand the library size (Hanes et al., 2000; Hudson and Souriau, 2003) , but the antibody is limited to a scFv, rather than a Fab fragment.

Bypassing phage display and panning is possible if immunoglobulin gene libraries are constructed from PBLs of immune patients with positive serology. Colony blot screening is a relatively old approach for this purpose (Helfman et al., 1983) . The principal of the method is shown in Fig. 8.3 . Plasmid vector is used for preparation of combinatorial immunoglobulin gene libraries, instead of use of a phagemid vector. The size of the library is smaller than that of a phage display library, but is sufficient for isolation of Fab fragments to major antigens of pathogens. The number of bacterial colonies screened using filter membranes is also limited to less than 5,000 per 82-mm filter (Fig. 8.4) . However, as shown in Table 8 .1, positive rates in the first screening by colony blotting were 0.006 to 0.05% to antigens from various pathogens. Plasma recovered during the isolation process of lymphocytes from peripheral blood of the donor can be used for detection of positive clones, instead of the use of monoclonal or polyclonal antibodies from immunized animals, if the donor's antibody titer for the target antigen is sufficient (Cheng et al., 2000) . The antibody fraction purified from the plasma is labeled with an enzyme such as horseradish peroxidase and then used for detection. By using a secondary antibody specific for the Fc region of human IgG, direct binding of the second antibody to a human Fab fragment produced in E. coli is also avoided in the case of indirect detection (Liu et al., 2006) . Although most of the positives in the first screening may become negative in the second and third screenings using ELISA or an indirect immunofluorescein antibody test, colony blotting is a simple and effective procedure for screening for human Fabs with neutralizing activity to pathogens. Screening by colony blotting is especially suitable for relatively small libraries such as chainshuffled libraries.

Screening of bacterial colonies using two filter membranes is also used (Skerra et al., 1991) . Bacteria secreting Fab fragments into the periplasm are grown on a membrane. The secreted Fab fragments are allowed to diffuse to a second membrane coated with anti-globulin, and are probed with antigen. The binding of antigen is detected on the second membrane using enzyme or colloidal gold conjugates. Positive colonies can be grown on the first membrane. The use of a filter membrane for screening is also applicable to phage-expressed antibody libraries (Wu et al., 1998) .

In this method, PBLs are collected from healthy human adult volunteers with high antibody titers to the target antigens. The PBLs are infected with Epstein-Barr virus (EBV) strain B95-8 at a dose of 10 5 transformation dose 50 (TD 50 )/mL, and plated on 96-well plates at 10 4 cells per well (Fig. 8.5) . Half of the medium is changed every 4 days and the culture is continued for 4 weeks without any treatment, including single isolation. During the process, EBV-transformed B lymphoblastoid cell lines (B-LCL) consisting of several clones are established (Takekoshi et al., 2001) . Antibody titers in the culture medium are then checked and the antibody-producing cells are expanded in a 6-cm dish. Cells and medium are harvested and total RNA is EBV-transformed B-LCL culture supernatants from a donor were found to be reactive with 71 target antigens (Table 8 .2) (Hamatake et al., 2010) . There was a tendency to produce autoantibodies, but autoantibody titers in the donor were normal. Using this method, Fab fragments against human cytomegalovirus (Takekoshi et al., 1998) , hepatitis B virus s-antigen (Maeda et al., 2005) , human tumor necrosis factor-alpha (Takekoshi et al., 2001) , ganglioside GM1 (Nagatsuka et al., 2003) , and human CD4 (Hamatake et al., 2010) have been obtained. Single isolations of EBVtransformed LCLs frequently cause loss of many clones, which may make it difficult to isolate monoclonal antibodies. However, with oligoclonal B-LCLs, immunoglobulin genes for positive clones are obtained at the semi-cloned level, and there is a low risk of loss of clones. Oligoclonal-LCLs can be stocked in a deep freezer for a long period, and genes for Fab fragments can be rescued by RT-PCR even if there is a loss of cell viability. TNF-alpha, IL-8, monocyte chemotactic protein (MCP)-1, and CD4 5. Glycolipids CMH (GlcCer), CDH (LacCer), CTH, Globoside, Forssman, paragloboside, CPH, Gal-CMH (Galactocerebroside), CSE (Sulfatide), NAGM3, NGGM3 (including N-glycosialic acid or HD antigen), blood group i-type antigen, glycosphingomyelin 1 (GM1), gangliotetraosylceramide 1 (GA1 or asialo-GM1), and GA2 6. Human blood cells B cells, T cells, NK cells, granulocytes, red blood cells, and 5 leukemic cell lines 7. Animal red blood cells Sheep, rabbit, chicken, and guinea pig

Fab fragments are produced in the periplasm of E. coli, and the expression of recombinant Fab in E. coli can vary significantly from antibody to antibody. Severe limitations in yield, folding and functionality are sometimes encountered in bacterial production of Fab fragments. The expression efficacy is affected by vector design and culture conditions; that is, the temperature and concentration of isopropyl-β-D-thiogalactopyranoside (IPTG) (Corisdeo and Wang, 2004; Shibui and Nagahari, 1992) . Many cases of successful expression have been shown at relatively low temperature and with gentle induction at a low IPTG concentration. The amount of antibody expressed also depends on its composition. Poor Fab expression is linked to poor intrinsic stability, whereas increases in Fab stability are correlated with higher Fab yields and higher levels of properly folded and functional protein (Demarest et al., 2006) . This is also affected by the growth rate of E. coli and secretion of Fab fragments into the medium. Limitations on protein expression may be overcome by single amino acid substitutions (Knappik and Pluckthun, 1995) . Storage of fragments in periplasmic spaces requires breaking of the outer membrane of the bacteria to release the fragments (Selisko et al., 2004; Takekoshi et al., 1998) .

Fab fragments can easily be purified from culture medium or an extracted fraction of bacteria if a tag such as a His-tag is added during the cloning process (Skerra, 1994; Tachibana et al., 2003) . The expression level of the light chain is sometimes higher than that of the Fd chain, and light chains also have a natural tendency to form homodimers, whereas Fd fragments do not usually dimerize. Therefore, attachment of a His-tag to the C-terminus of the Fd region is useful to avoid contamination of the purified fraction with light chain dimers. With this system, only functional heterodimers are purified. Affinity chromatography using anti-human Fab or antihuman F(ab')2 antibody is also used for purification of Fab fragments (Cheng et al., 2000; Takekoshi et al., 1998) .

In the human immune system, affinity of antibodies is matured in a stepwise fashion by incorporation of somatic hypermutation and selection of variants under increasing selective pressures. Various in vitro strategies have been used to maturate the affinity of recombinant Fab fragments (Hoogenboom, 2005) . These include chain shuffling, CDR shuffling, and site-directed or random mutagenesis. Site-specific mutagenesis uses modifications based on structural information, whereas random mutagenesis includes use of error-prone PCR (Gram et al., 1992) . Shuffling of light or heavy chain genes is effective for finding a better combination of heavy and light chains from the combinatorial library (Hur et al., 2010; Lou et al., 2010; Zhu et al., 2008) . When light chain genes are shuffled, the positive rates in colony blot screening are 10-to 20-fold higher than those in shuffling analysis of heavy chain genes (Tachibana et al., 2003) . If there is a loss or a partial deletion in the cloned gene, chain shuffling is also useful to find complete genes (Fu et al., 2011; Jia et al., 2008) .

Residues in the CDR, and especially in the CDR3 s of the heavy and light chains of the antibody, are thought to be responsible for high-affinity interactions with antigen. Therefore, an increased affinity may occur by mutation if the native residue exhibits a negative effect on the interaction. However, the effect of a mutation is not restricted to contact residues (Winkler et al., 2000) . For instance, the CDR3 of the light chain comprises amino acids 89-97 in the Kabat numbering system (Johnson and Wu, 2004; Wu and Kabat, 1970) . Although the residue at position 91 may not interact directly with antigenic molecules, it can affect the binding of residue 93 (Hall et al., 1992) . Thus, amino acid substitution at position 91 may result in a conformational change that allows redistribution of the neighboring amino acids involved in the antigen-antibody interaction. For site-directed mutagenesis, recombination PCR with high fidelity DNA polymerase is feasible to introduce amino acid substitution and improve the affinity of the original human Fab (Jones and Winistorfer, 1997; Tachibana et al., 2004) . The framework in the variable region is also important for establishing the correct conformation of the CDR loops, and mutations in the framework may affect the flexibility of the CDR loops.

It is possible to increase the affinity of antibody Fab fragments using various procedures, and the increased affinity may correlate with biological efficacy. However, if the original antibody already demonstrates high affinity above a threshold, the effect of affinity maturation on biological function may be limited (Hoogenboom, 2005; Tachibana et al., 2003) .

Phage display followed by panning is widely used for preparation of recombinant antibody Fab fragments from large combinatorial immunoglobulin gene libraries from naïve and immune donors. Here, we have shown that bypassing the phage display and panning processes is practical when immunoglobulin genes are derived from seropositive donors. Identification of bacterial colonies using membrane filters and donor plasma is useful for the initial screening of human Fab fragments to major antigenic molecules of pathogens. Preparation of immunoglobulin gene libraries from EB virus-transformed oligoclonal B-LCL can also be used for preparation of human Fab fragments to pathogens and self-antigens. Recently, a new technique bypassing the phage display platform has also been developed. B cells are cultured at near clonal density, culture supernatants are screened, and positives are used to clone authentic antibody genes (Walker et al., 2009) . Thus, improvement of technologies for antibody engineering is still in progress to generate high-affinity human antibodies.

Assembly of combinatorial antibody libraries on phage surfaces: the gene III site

Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro

Single-chain antigen-binding proteins

A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals

Production of high-affinity human monoclonal antibody fab fragments to the 19-kilodalton C-terminal merozoite surface protein 1 of Plasmodium falciparum

Entamoeba histolytica: bacterial expression of a human monoclonal antibody which inhibits in vitro adherence of trophozoites

Functional expression and display of an antibody Fab fragment in Escherichia coli: study of vector designs and culture conditions

A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies

Rapid selection of cell subpopulationspecific human monoclonal antibodies from a synthetic phage antibody library

Engineering stability into Escherichia coli secreted Fabs leads to increased functional expression

Generation of a neutralizing human monoclonal antibody Fab fragment to SAG1 of Toxoplasma gondii tachyzoites

In vitro selection and affinity maturation of antibodies from a naive combinatorial immunoglobulin library

A single amino acid mutation in CDR3 of the 3-14-9 L chain abolished expression of the IDA 10-defined idiotope and antigen binding

Inhibition of HIV replication by a CD4-reactive Fab of an IgM clone isolated from a healthy HIV-seronegative individual

Selecting and evolving functional proteins in vitro by ribosome display

Identification of clones that encode chicken tropomyosin by direct immunological screening of a cDNA expression library

Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity

Selecting and screening recombinant antibody libraries

Engineered antibodies

Development of the dual-vector system-III (DVS-III), which facilitates affinity maturation of a Fab antibody via light chain shuffling

Screening of human antibody Fab fragment against HBsAg and the construction of its dsFv form

The Kabat database and a bioinformatics example

Recombination and site-directed mutagenesis using recombination PCR

Linkage of recognition and replication functions by assembling combinatorial antibody Fab libraries along phage surfaces

Engineered turns of a recombinant antibody improve its in vivo folding

Inclusion of an upstream transcriptional terminator in phage display vectors abolishes background expression of toxic fusions with coat protein g3p

Cloned transchromosomic calves producing human immunoglobulin

Production of an anti-severe acute respiratory syndrome (SARS) coronavirus human monoclonal antibody Fab fragment by using a combinatorial immunoglobulin gene library derived from patients who recovered from SARS

Affinity maturation of human botulinum neurotoxin antibodies by light chain shuffling via yeast mating

Production and characterization of recombinant human anti-HBs Fab antibodies

Bypassing immunization. Human antibodies from V-gene libraries displayed on phage

Chimeric single-stranded DNA phage-plasmid cloning vectors

Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice

Human antibody libraries: a race to engineer and explore a larger diversity

Carbohydrate-dependent signaling from the phosphatidylglucoside-based microdomain induces granulocytic differentiation of HL60 cells

The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies

Filamentous phage assembly

Bacterial expression, purification and functional characterization of a recombinant chimeric Fab derived from murine mAb BCF2 that neutralizes the venom of the scorpion Centruroides noxius Hoffmann

De novo selection of high-affinity antibodies from synthetic Fab libraries displayed on phage as pIX fusion proteins

Secretion of a functional Fab fragment in Escherichia coli and the influence of culture conditions

Isolation of cell surface-specific human monoclonal antibodies using phage display and magnetically-activated cell sorting: applications in immunohematology

A general vector, pASK84, for cloning, bacterial production, and single-step purification of antibody Fab fragments

Filter screening of antibody Fab fragments secreted from individual bacterial colonies: specific detection of antigen binding with a two-membrane system

Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface

VH3 gene usage in neutralizing human antibodies specific for the Entamoeba histolytica Gal/GalNAc lectin heavy subunit

Improved affinity of a human anti-Entamoeba histolytica Gal/GalNAc lectin Fab fragment by a single amino acid modification of the light chain

Human monoclonal anti-HCMV neutralizing antibody from phage display libraries

Cloning and expression of human anti-tumor necrosis factor-alpha monoclonal antibodies from Epstein-Barr virus transformed oligoclonal libraries

Phage display derived therapeutic antibodies

Functional expression and germline transmission of a human chromosome fragment in chimaeric mice

Affinity maturation of Fab antibody fragments by fluorescent-activated cell sorting of yeast-displayed libraries

Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target

Retrieval of human antibodies from phage-display libraries using enzymatic cleavage

Changing the antigen binding specificity by single point mutations of an anti-p24 (HIV-1) antibody

Stepwise in vitro affinity maturation of Vitaxin, an alphav beta3-specific humanized mAb

An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity

Investigation of a tetracycline-regulated phage display system

Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody